Unique test allow to reveal hypertension in pregnant women before symptoms appear

Inform Bioscience company agreed to cooperate with the Mayo Clinic. The company is going to test the clinical analysis of urine, which should diagnose preeclampsia (hypertension in pregnant) just 26 weeks of pregnancy. As promised by the developers, the test will be ready for launch in the next 18 months.

As for today the test nas no analogues. Doctors have to diagnose the symptoms that have already appeared. Meanwhile, a dangerous disorder can develop covertly, threatening the lives of the pregnant woman and her baby. Moderate pre-eclampsia affects up to 10% of first pregnancies. A severe preeclampsia - up to 2%.

A characteristic features of this disease is high blood pressure, protein in the urine, fluid retention. Outcome can be abysmal - stroke, coma. Worldwide from preeclampsia die 80,000 women and 500,000 children. The children also develop cerebral palsy, blindness, epilepsy, deafness and lung disease. New test works on the basis of a biomarker that identifies a particular protein in the podocytes, kidney cells.

Based on: meddaily.ru

• The central office of IRTSA Ukraine completely restores work
• How we work during the COVID-19 pandemic
• 1st International Congress on Reproductive Law
• Soon Americans may face a new ethical dilemma
• ‘Friends’ star Jennifer Aniston is pregnant with twins
• Image processing technology can impact the success rates of ivf
• Editing genes of human embryos can became the next big thing in genetics
• Supermodel Tyra Banks undergoes IVF
• Scientists discovered a new, safer way for egg freezing
• French scientists have managed to grow human sperm cells in vitro